Five Prime Therapeutics, Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9f1f665b-32f6-4fc8-9bd7-56782a7ed245/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-92.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014463 |
| FY 2019 | $-141.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007407 |
| FY 2018 | $-146.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004472 |
| FY 2017 | $-151.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-003511 |
| FY 2016 | $-99.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002299 |
| FY 2015 | $287.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014596 |
| FY 2014 | $-37.6M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001804 |
| FY 2013 | $-29.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-114914 |
| FY 2012 | $-27.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-114914 |
| FY 2011 | $19.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-114914 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Five Prime Therapeutics, Inc. — all facts · Revenue · Net Income